The impact of Tegillarca granosa extract haishengsu on HL-60 cell
- PMID: 28352714
- PMCID: PMC5152984
- DOI: 10.1515/med-2015-0048
The impact of Tegillarca granosa extract haishengsu on HL-60 cell
Abstract
Haishengsu (Hss) is a purified protein from Tegillarca granosa that has been used as a traditional Chinese medicine to treat cancer for more than a century. In this study, we observed the impact of Haishengsu (Hss) on the proliferation and differentiation of HL-60 cells in the leukemic cell line by taking tretinoin and AS2O3 as a positive control and making a comparative analysis between the effect of Hss and tretinoin and AS2O3. We found that Hss could significantly inhibit the proliferation of HL-60 cells and caused most of the cells to stay in the G0/G1 phase. Its effect was much stronger than that of tretinoin and AS2O3, and the ability of Hss to induce differentiation was close to tretinoin. Hss functions probably by inhibiting the expression of the Bcl-2 and MPO genes and further promoting the expression of the Bax gene. Hss has a significant effect on both inhibiting the proliferation and inducing the differentiation of HL-60 cells. It is possible that Hss may be a new kind of clinical differentiation inducer.
Keywords: Cell differentiation; Leukemia; Tegillarca granosa.
Figures
Similar articles
-
[Mechanism Inducing the HL-60 Cell Differentiation by Haishengsu Tegillarca Granosa Extract via Targeting ULK1 Protein].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Feb;28(1):141-145. doi: 10.19746/j.cnki.issn.1009-2137.2020.01.024. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020. PMID: 32027267 Chinese.
-
Effect of a seashell protein Haishengsu on cell growth and expression of apoptosis genes in leukemia K562 cells.Clin Invest Med. 2008;31(4):E218-21. doi: 10.25011/cim.v31i4.4783. Clin Invest Med. 2008. PMID: 18682046
-
Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice.Adv Med Sci. 2013;58(1):112-7. doi: 10.2478/v10039-012-0069-8. Adv Med Sci. 2013. PMID: 23729583
-
Tretinoin tocoferil as a possible differentiation-inducing agent against myelomonocytic leukemia.Leuk Lymphoma. 1997 Jun;26(1-2):43-8. doi: 10.3109/10428199709109156. Leuk Lymphoma. 1997. PMID: 9250786 Review.
-
The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia.J Biol Regul Homeost Agents. 1999 Oct-Dec;13(4):195-200. J Biol Regul Homeost Agents. 1999. PMID: 10703942 Review.
References
-
- Dassonneville L, Wattez N, Baldeyrou B, Mahieu C, Lansiaux A, Banaigs B, et al. Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells. Biochem Pharmacol. 2000;60:527–537. - PubMed
-
- Wang S, Wang Z, Grant S. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms. Mol Pharmacol. 2003;63:232–242. - PubMed
-
- Li GY, Liu JZ, Zhang B, Yang M, Chen SG, Hou M, et al. Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice. Adv Med Sci. 2013;58:112–117. - PubMed
-
- Xu W, Chang Z, Liu X, Jiang C, Wang C, Xu L. Antitumor effects of a polypeptide isolated from Tegillarca granosa linnaeus and the related molecular mechanism. Pak J Pharm Sci. 2014;27:565–570. - PubMed
-
- Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, et al. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood. 1991;78:1413–1419. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous